Gynecologic Oncology

Gynecol Oncol · ISSN (print) 0090-8258 · ISSN (e) 1095-6859 · 338 papers in corpus
observational 2022
doi:10.1016/j.ygyno.2022.06.021 ·PMID:36357191

OBJECTIVE: The risk of developing endometrial hyperplasia after diagnosis of endometriosis has not been determined. Moreover, the risk of endometrial cancer associated with endometriosis is unclear. This nationwide population-based study in…

observational 2022
doi:10.1016/j.ygyno.2022.03.016 ·PMID:35370008

BACKGROUND: Clear cell and endometrioid ovarian carcinomas (OCC and OEC, respectively) have a presumed origin in endometriosis and share molecular alterations with each other and with their endometrial counterparts. The Cancer Genome Atlas …

observational 2022
doi:10.1016/j.ygyno.2022.07.025 ·PMID:35909004

OBJECTIVE: Endosalpingiosis is a poorly understood condition of ectopic epithelium resembling the fallopian tubes. It has been described as an incidental pathology finding, a disease similar to endometriosis, and in association with maligna…

rct 2021
doi:10.1016/j.ygyno.2021.01.010 ·PMID:33516531

OBJECTIVE: To investigate framing of active surveillance as a management option for cervical intraepithelial neoplasia (CIN)2 in women of childbearing age. METHODS: We conducted a between-subjects factorial (2 × 2) randomised experiment. W…

review 2021
doi:10.1016/j.ygyno.2021.06.033 ·PMID:34247767

Clear cell carcinoma of the ovary is a rare and distinct histotype of epithelial ovarian carcinomas. Women diagnosed with clear cell carcinomas are usually younger and diagnosed at earlier stages than those with the most common high-grade s…

other 2021
doi:10.1016/j.ygyno.2021.10.088 ·PMID:34776242

OBJECTIVE: To evaluate the association between hysterectomy and ovarian cancer, and to understand how hormone therapy (HT) use and endometriosis affect this association. METHODS: We conducted a pooled analysis of self-reported data from 11…

observational 2021
doi:10.1016/j.ygyno.2021.01.011 ·PMID:33504456

OBJECTIVES: In women with ovarian cancer, tumor features largely determine serum HE4 and CA125 levels, but non-tumor factors may also influence levels and be better understood by studying determinants in a well-characterized sample of women…

observational 2021
doi:10.1016/j.ygyno.2021.07.006 ·PMID:34266690

OBJECTIVE: Assessing the association between endometriosis and/or adenomyosis and ovarian cancer. METHODS: We identified all women with histological proven endometriosis (51,544 women) and/or adenomyosis (85,015 women) from the Dutch patho…

observational 2021
doi:10.1016/j.ygyno.2021.01.019 ·PMID:33514482

OBJECTIVE: To assess the cancer risk in a cohort of women with newly diagnosed endometriosis. METHODS: This retrospective, nationwide, population-based cohort study utilized data from the 10-year claims database of the Korean National Heal…

observational 2021
doi:10.1016/j.ygyno.2021.10.001 ·PMID:34649724

OBJECTIVE: We have previously shown that epithelial ovarian cancer (EOC) and its treatments have negative effects on long-term quality of life (QoL) and fatigue. The present multicenter study investigated the main menopausal symptoms and gy…

review 2021
doi:10.1016/j.ygyno.2021.07.032 ·PMID:34366148

Many women apply powder to the genital area as a drying agent. Talc, an inert mineral with a high capacity to absorb water, has historically been a major component of body powders. Due to its similarity and co-occurrence with asbestos, the …

other 2020
doi:10.1016/j.ygyno.2020.06.501 ·PMID:33087246
observational 2020
doi:10.1016/j.ygyno.2019.09.014 ·PMID:31718832

OBJECTIVE: To evaluate endometrial cancer (EC) risk assessment and early detection strategies in high-risk populations, we designed a large, prospective cohort study of women undergoing endometrial evaluation to assess risk factors and coll…

observational 2020
doi:10.1016/j.ygyno.2020.01.027 ·PMID:31983516

OBJECTIVE: Risk factors for ovarian borderline tumors and low-grade serous carcinoma (LGSC) are poorly understood. The aim of this study was to examine the association between infertility, pelvic inflammatory disease (PID), endometriosis, e…

other 2020
doi:10.1016/j.ygyno.2019.11.124 ·PMID:31839337

OBJECTIVE: Pap tests hold promise as a molecular diagnostic for serous ovarian cancer, but previous studies reported limited sensitivity. Furthermore, the presence of somatic mutations in normal tissue is increasingly recognized as a challe…

diagnostic-accuracy 2020
doi:10.1016/j.ygyno.2019.11.028 ·PMID:31787246

OBJECTIVE: We aimed to assess whether endometrial cancer (EC) can be detected in shed DNA collected with vaginal tampon by analyzing copy number, methylation markers, and mutations. METHODS: Tampons were collected prior to hysterectomy fro…

lab-animal 2020
doi:10.1016/j.ygyno.2020.06.484 ·PMID:32600791

OBJECTIVE: Whole-exome-sequencing (WES) studies reported c-MYC gene-amplification and HUWE1 gene deletion/mutations in a significant number of cervical-cancer-patients (CC) suggesting HUWE1/c-MYC pathway as potential therapeutic target. We …

observational 2020
doi:10.1016/j.ygyno.2020.07.004 ·PMID:32718730

OBJECTIVE: To evaluate the feasibility of an electronic symptom-tracking platform for patients recovering from ambulatory surgery. METHOD: We assessed user response to an electronic system designed to self-report symptoms. Endpoints includ…

other 2020
doi:10.1016/j.ygyno.2020.02.013 ·PMID:32059865
observational 2020
doi:10.1016/j.ygyno.2020.02.028 ·PMID:32122688

OBJECTIVE: While genitourinary complications during treatment for ovarian cancer are well-known, long-term adverse outcomes have not been well characterized. The number of ovarian cancer survivors has been increasing. The aim of this study …

observational 2020
doi:10.1016/j.ygyno.2019.12.037 ·PMID:31952842

OBJECTIVE: Germline pathogenic variation in DICER1 underlies a tumor-predisposition disorder with increased risk for cervical embryonal rhabdomyosarcoma and ovarian sex-cord stromal tumors, particularly Sertoli-Leydig cell tumors. The gynec…

other 2020
doi:10.1016/j.ygyno.2020.05.030 ·PMID:32723676

BACKGROUND: SEER-reported cervical cancer incidence rates reflect the total female population including women no longer at risk due to hysterectomy. Hysterectomy rates have been declining in the United States as alternative treatments have …

other 2020
doi:10.1016/j.ygyno.2019.12.015 ·PMID:31902686

OBJECTIVE: Mucinous ovarian carcinoma (MOC) is an uncommon ovarian cancer histotype that responds poorly to conventional chemotherapy regimens. Although long overall survival outcomes can occur with early detection and optimal surgical rese…

review 2020
doi:10.1016/j.ygyno.2020.06.001 ·PMID:32532460

The COVID-19 pandemic has challenged our ability to provide timely surgical care for our patients. In response, the U.S. Surgeon General, the American College of Srugeons, and other surgical professional societies recommended postponing ele…

other 2019
doi:10.1016/j.ygyno.2019.04.650 ·PMID:31109661